NIBAN1 overexpression has been reported in a wide range of thyroid carcinoma subtypes, and in other cancers, while it is not expressed in thyroid benign lesions and normal thyroid.1, 2, 3 However, the mechanism associated with its expression and prognostic value remains unclear. This evidence concerns the gene NIBAN1 and thyroid gland disorder.